No Backward Move On French Reforms: Barrot

11 May 1997

French government health sector reforms will continue, despite theopening of the election campaign, Social Affairs Minister Jacques Barrot has said in Paris. "There is no possibility for any government of marching backwards," he added.

Decrees on hospital reform, computerization of medical practice and supervision of the health funds and other health service matters have all been issued in the last several days. Mr Barrot and Health Secretary Herve Gaymad have underlined their conviction that once the misunderstandings which have led to the recent strikes and protests are behind them, the doctors in France will realize that it is actually in their best interest to "co-manage" the reforms with a prevailing majority government.

"Economic Actors" Role Both the ministers want to see the medical professionals as "economic actors" in the reforms without abandoning the quality of health care. The ministers have indicated that beyond the current conflicts, they expect to see a renewal of the framework agreements with the medical professions and the first phase of mergers and concentration in the unwieldy and costly hospital sector.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight